Zobrazeno 1 - 10
of 24
pro vyhledávání: '"JAVID RASOOL BHAT"'
Autor:
Afaq Khan, Reshma Roshan, Sajad Ahmed Geelani, Santosh Govind Rathod, Aakash Chozakade, Javid Rasool Bhat, J Sherook
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 12, Pp 05-08 (2023)
Historically, relapsed and refractory Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML) have been associated with a dismal prognosis. Relapse-refractory ALL is associated with cure rates of
Externí odkaz:
https://doaj.org/article/81e41587e2b644a5b994e6020dfe47ef
Autor:
Javid Rasool Bhat, Sajad Ahmed Geelani, Afaq Ahmad Khan, Reshma Roshan, Santosh Govind Rathod
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 11, Iss 4, Pp 1561-1563 (2022)
Apart from maintaining healthy bones, vitamin D is also required for cell differentiation, cell growth inhibition, and immune modulation. Vitamin D deficiency is common in the Indian subcontinent. Vitamin D presenting toxicity, leading to hypercalcem
Externí odkaz:
https://doaj.org/article/77ebd1ef3acf4521a69220089780acbe
Autor:
Santosh Govind Rathod, Afaq Ahmad Khan, Sajad Ahmed Geelani, Reshma Roshan, Javid Rasool Bhat
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 6, Pp XD01-XD03 (2022)
Dasatinib is a potent inhibitor of BCR-ABL (break point cluster-Abelson) kinase, Src family of kinases, C-kit, and Platelet Derived Growth Factor Receptor beta (PDGFR-beta), and used in the treatment of Chronic Myeloid Leukaemia (CML), Ph-positive ac
Externí odkaz:
https://doaj.org/article/642aca79157441e49a773483f664bb25
Autor:
Reshma Roshan, Sajad Ahmed Geelani, Santosh Govind Rathod, Afaq Ahmad Khan, Aakash Chozakade, Ayeshah Jalid, Javid Rasool Bhat
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1416-1417 (2022)
Externí odkaz:
https://doaj.org/article/142f8a3d5a0345569b1f934974d34117
Autor:
Yasir Bashir Khan, Asif Ahmed, Syed Sajad Geelani, Shabeer Ahmad Mir, Javid Rasool Bhat, Nusrat Bashir, Javeed Iqbal Bhat
Publikováno v:
Journal of Applied Hematology, Vol 5, Iss 3, Pp 86-90 (2014)
Objective: The aim was to evaluate the efficacy and safety profile of dapsone as a cheap second-line treatment for chronic immune thrombocytopenia (ITP) in developing countries. Materials and Methods: A prospective study on 100 chronic ITP patients.
Externí odkaz:
https://doaj.org/article/0ed98afefd414ba28deea2d763a71539
Publikováno v:
South Asian Journal of Cancer, Vol , Iss
Externí odkaz:
https://doaj.org/article/9e736aca9fb1479ba16949f57d267537
Autor:
AFAQ AHMAD KHAN, RESHMA ROSHAN, NISAR AHMAD KHAN, SANTOSH GOVIND RATHOD, SAJAD AHMED GEELANI, JAVID RASOOL BHAT
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :161-163
Objective: In the present study, we are reporting the clinical profile; and outcomes of COVID-19 in patients with hematological malignancy at tertiary care hospitals. Methods: Data from laboratory-confirmed 40 COVID-19 patients diagnosed between Janu
Autor:
Santosh Govind Rathod, Afaq Ahmad Khan, Sajad Ahmed Geelani, Reshma Roshan, Javid Rasool Bhat
Publikováno v:
Tropical Doctor. 52:357-359
Snake bite is an acute life threating medical emergency and is included amonst neglected tropical diseases. 1 Every year in India 200,000 people bitten by snakes and >25% are fatal. 2 In Maharashtra, Konkan area, the green pit viper (Trimeresurus gra
Autor:
Sajad Geelani, Zafar A. Shah, Ayaz Gul, Arshad A. Pandith, Javid Rasool Bhat, Mohammad Muzaffar Mir, Shahid M. Baba, Gul Mohammad Bhat
Publikováno v:
International Journal of Laboratory Hematology. 43:1000-1008
INTRODUCTION Glutathione S-transferase (GST) gene deletion or polymorphic sequence variations lead to decreased enzyme activity that influences susceptibility and response to tyrosine kinase inhibitors in chronic myeloid leukemia (CML). We aimed to a
Autor:
Shahid M. Baba, Arshad A. Pandith, Mohammad Muzaffar Mir, Zafar A. Shah, Sajad Geelani, Javid Rasool Bhat, Gul Mohammad Bhat
Publikováno v:
Indian J Hematol Blood Transfus
Inherited polymorphic sequence variations in drug transport genes like ABCB1 impact a portion of patients with hematologic malignancies that show intrinsic or acquire resistance to treatment. Keeping in view inter-individual sensitivities for such dr